These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 15217454

  • 1. Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation.
    Coxon JP, Oades GM, Kirby RS, Colston KW.
    BJU Int; 2004 Jul; 94(1):164-70. PubMed ID: 15217454
    [Abstract] [Full Text] [Related]

  • 2. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM, Senaratne SG, Clarke IA, Kirby RS, Colston KW.
    J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
    [Abstract] [Full Text] [Related]

  • 3. Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
    Clyburn RD, Reid P, Evans CA, Lefley DV, Holen I.
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):969-78. PubMed ID: 19730863
    [Abstract] [Full Text] [Related]

  • 4. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y, Varol U, Atmaca H, Kisim A, Sezgin C, Karabulut B, Uzunoglu S, Uslu R, Karaca B.
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [Abstract] [Full Text] [Related]

  • 5. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
    Goffinet M, Thoulouzan M, Pradines A, Lajoie-Mazenc I, Weinbaum C, Faye JC, Séronie-Vivien S.
    BMC Cancer; 2006 Mar 15; 6():60. PubMed ID: 16539721
    [Abstract] [Full Text] [Related]

  • 6. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
    Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R.
    Cancer Res; 2005 Feb 01; 65(3):1035-44. PubMed ID: 15705905
    [Abstract] [Full Text] [Related]

  • 7. Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.
    Montague R, Hart CA, George NJ, Ramani VA, Brown MD, Clarke NW.
    Eur Urol; 2004 Sep 01; 46(3):389-401; discussion 401-2. PubMed ID: 15306113
    [Abstract] [Full Text] [Related]

  • 8. Zoledronic acid determines S-phase arrest but fails to induce apoptosis in cholangiocarcinoma cells.
    Romani AA, Desenzani S, Morganti MM, La Monica S, Borghetti AF, Soliani P.
    Biochem Pharmacol; 2009 Jul 15; 78(2):133-41. PubMed ID: 19464430
    [Abstract] [Full Text] [Related]

  • 9. [Induction of apoptosis by mifepristone in androgen-independent prostate cancer cell lines in vitro].
    Zhang H, Lü JJ, Gao QZ, Zhang J.
    Zhonghua Wai Ke Za Zhi; 2006 Mar 15; 44(6):382-5. PubMed ID: 16638347
    [Abstract] [Full Text] [Related]

  • 10. The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel.
    Jagdev SP, Coleman RE, Shipman CM, Rostami-H A, Croucher PI.
    Br J Cancer; 2001 Apr 20; 84(8):1126-34. PubMed ID: 11308265
    [Abstract] [Full Text] [Related]

  • 11. Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines.
    Ullen A, Schwarz S, Lennartsson L, Kalkner KM, Sandstrom P, Costa F, Lennernas B, Linder S, Nilsson S.
    Scand J Urol Nephrol; 2009 Apr 20; 43(2):98-103. PubMed ID: 19101859
    [Abstract] [Full Text] [Related]

  • 12. The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro.
    Mitrofan LM, Pelkonen J, Mönkkönen J.
    Bone; 2009 Dec 20; 45(6):1153-60. PubMed ID: 19699819
    [Abstract] [Full Text] [Related]

  • 13. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 20; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 14. Bone microenvironment-related growth factors, zoledronic acid and dexamethasone differentially modulate PTHrP expression in PC-3 prostate cancer cells.
    Tenta R, Sourla A, Lembessis P, Luu-The V, Koutsilieris M.
    Horm Metab Res; 2005 Oct 20; 37(10):593-601. PubMed ID: 16278781
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells.
    Huang YW, Wang LS, Chang HL, Ye W, Dowd MK, Wan PJ, Lin YC.
    Anticancer Res; 2006 Oct 20; 26(3A):1925-33. PubMed ID: 16827126
    [Abstract] [Full Text] [Related]

  • 16. Mitogenic and anti-apoptotic actions of adipocyte-derived hormone leptin in prostate cancer cells.
    Hoda MR, Popken G.
    BJU Int; 2008 Aug 20; 102(3):383-8. PubMed ID: 18341625
    [Abstract] [Full Text] [Related]

  • 17. Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells.
    Iguchi K, Tatsuda Y, Usui S, Hirano K.
    Eur J Pharmacol; 2010 Sep 01; 641(1):35-40. PubMed ID: 20519142
    [Abstract] [Full Text] [Related]

  • 18. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Virtanen SS, Väänänen HK, Härkönen PL, Lakkakorpi PT.
    Cancer Res; 2002 May 01; 62(9):2708-14. PubMed ID: 11980672
    [Abstract] [Full Text] [Related]

  • 19. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
    Hyer ML, Shi R, Krajewska M, Meyer C, Lebedeva IV, Fisher PB, Reed JC.
    Cancer Res; 2008 Apr 15; 68(8):2927-33. PubMed ID: 18413762
    [Abstract] [Full Text] [Related]

  • 20. Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
    Dumon JC, Journé F, Kheddoumi N, Lagneaux L, Body JJ.
    Eur Urol; 2004 Apr 15; 45(4):521-8; discussion 528-9. PubMed ID: 15041119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.